The premier Asia-Pacific biopharma conference for global cross-border partnerships
The Asia Bio Partnering Forum program is developed to highlight the powerful rise of innovation in the Asia-Pacific life science market.
Explore the themes shaping biotech and medtech partnerships in 2026:
Where Asia’s biotech partnerships take shape
Built around today’s partnering priorities, the program brings together biotech, medtech, pharma, and investors shaping the next wave of cross-border growth across Asia.
Investment & Deal-Making
Hear how investors, biotech leaders, and pharma dealmakers are approaching licensing, funding, M&A, and cross-border partnerships in today’s market.
R&D & Innovation
Explore the technologies, platforms, and therapeutic advances reshaping biotech and medtech across Asia.
Market Access & Collaboration
Understand the regulatory, commercial, and strategic realities of expanding across Asian and global markets.
Startup Spotlight
Meet emerging biotech companies pitching live to investors, pharma, and potential partners.
BioSyndicate: Asia Bio Partnering Forum Investor Workshop
Key Information
🔹 Date: Monday 31 August, 2026 (Preceding Asia Bio Partnering Forum)
🕐 Time: 1:00pm – 5:00pm (Drinks Reception to Follow)
📍 Location: Marina Bay Sands, Singapore
Exclusive Investor-Only Workshop on August 31 focused on syndication strategies in the Asian biotech landscape
Pre-conference session providing valuable insights into:
• Biotech investment & syndication
• Medtech investment & syndication
Attendees will engage with thought leaders in panel discussions covering the next wave of biotech investment in Asia, practical syndication strategies, and future market predictions.
Event culminates with a networking reception, offering valuable opportunities to connect with potential investment partners.
Perfect for investors seeking to understand cross-border funding collaborations, de-risking strategies, and emerging trends in the Asian biotech ecosystem.
Focused on syndication strategies in biotech and medtech investment.
Asia Bio Partnering Forum / Medtech leaders joint program sessions
Asia Bio Partnering Forum session highlights
✅ APAC dealmaking in 2026: Where capital meets opportunity
Explore where partnering momentum is accelerating across Asia-Pacific and what’s driving global pharma interest in the region
✅ What pharma really wants: Partnering priorities for 2026
Senior BD leaders discuss evolving priorities, common deal-breakers, and what genuinely captures attention in an increasingly crowded market
✅ License, co-develop, or build? Rethinking partnership models
Discover how APAC biotech companies are rethinking licensing, co-development, and long-term value creation
✅ Inside the deal: Lessons from recent Biotech partnerships
Industry leaders unpack the strategy, negotiation, and relationship-building behind successful APAC biotech deals
Medtech Leaders session highlights
✅ Spotlight on medtech in the Asia-Pacific: Opportunities, challenges, and the road ahead
Build a roadmap for innovation, collaboration, and commercialization
✅ Engaging tier 1 Medtech and pharma: Unlocking strategic partnerships
Explore how startups can effectively engage industry giants for growth and innovation
✅ Securing family office investment: Medtech and digital health startups
Tap into alternative funding sources driving innovation
✅ Breaking into the US market: A roadmap for Asia-Pacific Medtech startups
Understand the unique dynamics of the US medtech market for APAC startups
2026 - Advisory board
Meet our distinguished Advisory Board - industry leaders and innovators shaping the future of biotech in Asia-Pacific. Their collective expertise spans biotech, pharmaceuticals, investment, and strategic partnerships, ensuring our program delivers cutting-edge insights and meaningful connections for the life sciences community. These thought leaders guide our mission to foster cross-border collaboration and accelerate innovation across the region's dynamic biotech ecosystem.